These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22577776)

  • 1. The effect of pimecrolimus on innate immunity in subjects with atopic dermatitis: a double-blind, randomized, vehicle-controlled study.
    Afshar M; Kotol P; Miller J; Gallo R; Hata T
    Br J Dermatol; 2013 Feb; 168(2):426-8. PubMed ID: 22577776
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of pimecrolimus on the innate immune response in atopic dermatitis.
    Danby SG; Cork MJ
    Br J Dermatol; 2013 Feb; 168(2):235-6. PubMed ID: 23362967
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of pimecrolimus 1% cream in the long term management of atopic hand dermatitis. A double-blind RCT.
    Bauer A; Lange N; Matterne U; Meurer M; Braeutigam M; Diepgen TL
    J Dtsch Dermatol Ges; 2012 Jun; 10(6):426-33. PubMed ID: 22112014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and cytological effects of pimecrolimus cream 1% after resolution of active atopic dermatitis lesions by topical corticosteroids: a randomized controlled trial.
    Bangert C; Strober BE; Cork M; Ortonne JP; Luger T; Bieber T; Ferguson A; Ecker RC; Kopp T; Weise-Riccardi S; Guettner A; Stingl G
    Dermatology; 2011 Feb; 222(1):36-48. PubMed ID: 21150167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.
    Gollnick H; Kaufmann R; Stough D; Heikkila H; Andriano K; Grinienko A; Jimenez P;
    Br J Dermatol; 2008 May; 158(5):1083-93. PubMed ID: 18341665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants.
    Ho VC; Gupta A; Kaufmann R; Todd G; Vanaclocha F; Takaoka R; Fölster-Holst R; Potter P; Marshall K; Thurston M; Bush C; Cherill R
    J Pediatr; 2003 Feb; 142(2):155-62. PubMed ID: 12584537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spotlight on topical pimecrolimus in pediatric atopic dermatitis.
    Yang LP; Curran MP
    Am J Clin Dermatol; 2010; 11(4):295-8. PubMed ID: 20509720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease.
    Zuberbier T; Bräutigam M
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):718-21. PubMed ID: 18312323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both pimecrolimus and corticosteroids deplete plasmacytoid dendritic cells in patients with atopic dermatitis.
    Hoetzenecker W; Meindl S; Stuetz A; Stingl G; Elbe-Bürger A
    J Invest Dermatol; 2006 Sep; 126(9):2141-4. PubMed ID: 16691192
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis.
    Sigurgeirsson B; Ho V; Ferrándiz C; Andriano K; Grinienko A; Jimenez P;
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1290-301. PubMed ID: 18624866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tacrolimus and pimecrolimus ointments in the treatment of atopic eczema].
    Reitamo S; Remitz A
    Duodecim; 2003; 119(9):825-7. PubMed ID: 12815980
    [No Abstract]   [Full Text] [Related]  

  • 13. Review of pimecrolimus cream 1% in children for the treatment of mild to moderate atopic dermatitis.
    Cohen B
    Clin Pediatr (Phila); 2007 Jan; 46(1):7-15. PubMed ID: 17164503
    [No Abstract]   [Full Text] [Related]  

  • 14. Pimecrolimus 1% cream for perianal atopic dermatitis.
    Kreuter A; Hochdorfer B; Altmeyer P; Gambichler T
    Br J Dermatol; 2005 Jan; 152(1):186-7. PubMed ID: 15656832
    [No Abstract]   [Full Text] [Related]  

  • 15. Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial.
    Spergel JM; Boguniewicz M; Paller AS; Hebert AA; Gallagher PR; McCormick C; Parneix-Spake A; Hultsch T
    Br J Dermatol; 2007 Aug; 157(2):378-81. PubMed ID: 17573885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    van der Laan JR
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1816; author reply 1817. PubMed ID: 16121669
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical treatment for atopic dermatitis in the 21st century.
    Johnson SM; Kincannon JM; Dudney DL;
    J Ark Med Soc; 2004 Sep; 101(3):86-90. PubMed ID: 15384500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis.
    Hoetzenecker W; Ecker R; Kopp T; Stuetz A; Stingl G; Elbe-Bürger A
    J Allergy Clin Immunol; 2005 Jun; 115(6):1276-83. PubMed ID: 15940147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin physiological parameters confirm the therapeutic efficacy of pimecrolimus cream 1% in patients with mild-to-moderate atopic dermatitis.
    Aschoff R; Schwanebeck U; Bräutigam M; Meurer M
    Exp Dermatol; 2009 Jan; 18(1):24-9. PubMed ID: 18637133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.